News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Bayer AG (BAYZF) Unveils Plan To Sell Plastics Business; Will Focus Solely On Life Sciences     9/18/2014
Auxilium Pharmaceuticals (AUXL), VIVUS, Inc. (VVUS)'s Faster-Acting Erectile Dysfunction Drug Wins FDA Approval     9/18/2014
Merck KGaA (MKGAF.PK) Appoints Pharma Head Oschmann As Deputy CEO     9/18/2014
Roche (RHHBY) To Invest $535M, Create 3,500 Jobs At New Swiss IT Site     9/17/2014
Novo Nordisk A/S (NVO) May Add Hundreds To R&D Staff For Obesity Medicines     9/17/2014
Gilead Sciences, Inc. (GILD)'s Experimental Drug Simtuzumab Fails Mid-Stage Study     9/17/2014
Auxilium Pharmaceuticals (AUXL) Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals (ENDP) Offer     9/17/2014
South San Francisco's Sutro Biopharma Forges $298 Million Antibody Drug Pact With Merck KGaA (MKGAF.PK)     9/17/2014
Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France) (SAN.PA)     9/17/2014
Salix Pharmaceuticals, Ltd. (SLXP) Faces Shareholder Revolt On Cosmo Pharmaceuticals S.p.A. Deal     9/17/2014
Moving On From A Botched Novartis AG (NVS) Deal, Proteon Therapeutics, Inc. Turns To Plan B: IPO     9/17/2014
Tokai Pharmaceuticals Bags $97 Million For Prostate Cancer Drug In Upsized IPO     9/17/2014
Asian Investor In Talks To Buy, Build Massive Burlingame Site; Will It Hold Biotech Or Tech Tenants?     9/17/2014
Looming Patent Deadline Pushes Sanofi (France) (SAN.PA) To Be More Aggressive; Wants To Add Oral GLP-1 To Diabetes Offering     9/17/2014
Analyst: Gilead Sciences, Inc. (GILD) Still A Buy After Cancer Drug Fail     9/17/2014

Featured Stories
For Roche (RHHBY) CEO, Celebrating Failure Is Key To Success     9/17/2014
What Ralph Nader Gets Wrong About Big Pharma     9/17/2014
Parkinson's Disease Myth Debunked, University of Copenhagen Study     9/17/2014
American Waistlines Continues To Expand At Alarming Rate, Centers for Disease Control and Prevention (CDC) Reveals     9/17/2014
Failing Students Saved By Stress-Detecting App, Dartmouth College Study     9/17/2014
Human Faces Are Evolved To Look Unique, University of California, Berkeley (CAL) Study     9/17/2014
Aggressive People React Differently To Media Violence, Mount Sinai School of Medicine Study     9/17/2014
How You Pick Romantic Partners Could Be A Matter Of Tiny Words, University of Texas Study     9/17/2014
Cardiorespiratory Fitness Slashes High Blood Pressure Hikes In Men, University of South Carolina Study     9/17/2014
Top 10 Fastest Growing Employers Outside Of Big Pharma     9/16/2014
India’s Dept Of Biotech Plans Financial Help For The Biotech Industry     9/16/2014
Too Many Science PhDs? Not If Universities Train Them For Careers Outside Academia     9/16/2014
Pfizer (PFE) And Merck & Co. (MRK) Execs Exclusive: Inside Tips For Getting Hired     9/16/2014
Schizophrenia Is Actually Eight Different Diseases, Washington University in St. Louis Study     9/16/2014
You're Attracted To The Body Odor Of Those With Similar Political Beliefs, American Journal Of Political Science Reveals     9/16/2014

More News
Jaguar Animal Health, Inc. Files Eighth Investigational New Animal Drug Application     9/17/2014
Achaogen (AKAO) Announces First Patient Enrollment In A Phase 3 Clinical Trial Of Plazomicin To Treat Infections Caused By Carbapenem-Resistant Enterobacteriaceae (CRE)     9/17/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback On ICT-107 Supporting Advancement To Registrational Phase 3 Testing In Newly Diagnosed Glioblastoma     9/17/2014
Soligenix (SNGX) Announces FDA Clearance Of Phase 3 Clinical Protocol Of SGX301 In Cutaneous T-Cell Lymphoma     9/17/2014
Merck & Co. (MRK) Presents First Phase 3 Data In Japanese Patients For Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes     9/17/2014
Janssen-Cilag International NV (JNJ) Release: Analysis Of Pooled Data From Phase 3 Trial Results Show Glycaemic Efficacy Of INVOKANA® (Canagliflozin) Is Largely Independent Of Beta-Cell Function And Insulin Sensitivity In The Treatment Of Type 2 Diabetes In Adults     9/17/2014
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of RSV F-Protein Nanoparticle Vaccine Candidate In Healthy Third-Trimester Pregnant Women     9/17/2014
BioBlast Pharma (ORPN) Announces Preclinical And Clinical Pharmacokinetic Results With Cabaletta, Interim Safety Results From Phase 2/3 HOPEMD Study In OPMD     9/17/2014
Glenmark Pharmaceuticals's TRPA1 Antagonist 'GRC 17536' Shows Positive Data In A Proof Of Concept Study     9/17/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Successful Results For MOB-015 In A Phase II Study For The Treatment Of Onychomycosis     9/17/2014
Amarantus BioSciences, Inc. Provides Program Update On Phase 2b Eltoprazine For Parkinson's Disease And Adult ADHD     9/17/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Overall And KRAS-Mutated Patient Data From U.S. Randomized Phase 2 Pancreatic Cancer Study     9/17/2014
Concert Pharmaceuticals, Inc. (CNCE) Announces Initiation Of CTP-730 Phase 1 Clinical Trial Under Celgene (CELG) Collaboration     9/17/2014
Janssen-Cilag International NV (JNJ) Release: Results From Head-To-Head Studies Of INVOKANA® (Canagliflozin) Versus JANUVIA (Sitagliptin) Highlight The Importance Of Weight-Change On Quality Of Life And Cost Effectiveness Of Canagliflozin Among People With Type 2 Diabetes     9/17/2014
BioLineRx Ltd. Presents Positive Preclinical Results In Treatment For AML Patients With FLT3 Mutations     9/17/2014
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Ltd. Demonstrates The Safety And Efficacy Of Opregen® In Preclinical Animal Studies     9/17/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV     9/17/2014
Rox Medical Inc. Presents Positive Data For CONTROL-HTN Resistant Hypertension Trial     9/17/2014
St. Jude Children's Research Hospital Release: Improved Risk Identification Will Aid Fertility Preservation In Young Male Cancer Patients     9/17/2014
Denovo Biopharma Acquires Late-Stage Oncology Drug From Eli Lilly and Company (LLY) For Development As A Personalized Medicine     9/17/2014
QLT Inc. (QLTI) Provides Update On Merger With Auxilium Pharmaceuticals (AUXL)     9/17/2014
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site     9/17/2014
Protein Sciences Corporation And Diamyd Medical AB Deepen Commitment To Develop New Treatment For Diabetes     9/17/2014
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize Pixuvri®     9/17/2014
3SBio Inc. (SSRX) Obtains Exclusive Licenses To Develop And Market Jenkem's PEG-Irinotecan In China     9/17/2014
Champions Oncology, Inc. (CSBR) Partners With Sarcoma Alliance To Bring Personalized Treatment Options To Sarcoma Patients     9/17/2014
NuView Life Sciences Inc. Enters Global Licensing Agreement With Otsuka Pharmaceutical Co., Ltd.     9/17/2014
PharmaVentures Ltd Advises MedGenesis Therapeutix In Agreement For Its Potential Therapy For Parkinson's Disease.     9/17/2014
Hetero Enters License Agreement With Gilead Sciences, Inc. (GILD), U.S.A. To Produce Generic Sofosbuvir For Treatment Of Chronic Hepatitis C     9/17/2014
Metabolon's Quantose™ Prediabetes Tests Now Available in Europe Through Collaboration With Metdia Biotech     9/17/2014
Elevance Expands Customer Service And Support Capabilities With E-360 Collaboration     9/17/2014
Covance Inc. (CVD) And Frenova Renal Research Establish Innovative Research Collaboration     9/17/2014
The Michael J. Fox Foundation Forms New Partnership With The Bachmann-Strauss Dystonia And Parkinson Foundation     9/17/2014
ContraFect Corporation (CFRXU)'s Universal Influenza Treatment Receives SBIR Funding     9/17/2014
New Product From Vireo Systems: pH-D Feminine Health Support     9/17/2014
Regen BioPharma Files Patent Application On New Therapy That Uses the "Innate" Immune System To Kill Cancer     9/17/2014
Avraham Pharmaceuticals Ltd. Raises $4.5 Million In Additional Investment Led By Yissum     9/17/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $4 Million From Achaogen (AKAO) For The Initiation Of A Phase 3 Study Of Plazomicin     9/17/2014
Qu Biologics Closes Oversubscribed Private Funding Round Of CDN$5.1 Million     9/17/2014
Aratana Therapeutics (PETX) Announces Proposed Public Offering     9/17/2014
FEI Company Announces Quarterly Cash Dividend Of $0.25 Per Share     9/17/2014
Auxilium Pharmaceuticals (AUXL) Responds To Unsolicited Proposal From Endo International plc (ENDP)     9/17/2014
Aastrom Biosciences, Inc. (ASTM) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares     9/17/2014
MGB Biopharma Limited Secures $6.4 MillionTo Advance Its Novel Lead Antibacterial, MGB-BP-3, Into Clinical Development     9/17/2014
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants     9/17/2014
Synereca Pharmaceuticals Announces Financing Led By Accele Venture Partners     9/17/2014
Novadaq Corp. To Host Analyst & Investor Day On November 17, 2014     9/17/2014
Chindex International, Inc. (CHDX) Stockholders Approve Merger     9/17/2014
Caris Life Sciences Selects IBM Corporation (IBM) To Accelerate Use Of Molecular Profiling In Cancer Treatment Selection     9/17/2014
RXi Pharmaceuticals (RXII) Strengthens Intellectual Property Portfolio     9/17/2014
PTC Therapeutics, Inc. (PTCT) Expands Global Presence In Support Of Translarna™ Launch In Duchenne Muscular Dystrophy     9/17/2014
Tokai Pharmaceuticals Announces Pricing Of Initial Public Offering     9/17/2014
ImaginAb, Inc. Expands ImmunoPET Pipeline To Include CD4+ T-Cell Imaging     9/17/2014
Imagenetix, Inc. (IAGX) Successfully Emerges From Bankruptcy     9/17/2014
Celator Pharmaceuticals, Inc. To Ring The NASDAQ Stock Market Closing Bell On September 17, 2014     9/17/2014
SAFE-BioPharma, LLC Trust Framework Approves Doximity As Identity Proofing Component Member     9/17/2014
Aspen Institute Launches New Partnership with Friends of Cancer Research     9/17/2014
Plandai Biotechnology, Inc. (PLPL.OB) Gains Competitive Advantage With Preliminary Clinical Trial Results     9/17/2014
Wound Management Technologies, Inc. Launches Free Investor Relations App     9/17/2014
Fluidigm Corporation’s New JunoTM System Shatters Barriers For SNP Genotyping     9/17/2014
Peter Thiel Opens Application Period For 2015 Thiel Fellowships     9/17/2014
Eagle Pharmaceuticals (EGRX) Announces That Teva Pharmaceutical Industries Limited (TEVA) Requests A Motion To Dismiss With Prejudice In Its Bendamustine Patent Infringement Lawsuit     9/17/2014
Acura Pharmaceuticals, Inc. (ACUR) Submits Formal Dispute Resolution Request With FDA Regarding Hydrocodone Bitartrate With Acetaminophen Tablets     9/17/2014
Foster Delivery Science To Build Facility For Manufacturing Drug Delivery Polymers     9/17/2014
Innate Pharma (IPH.PA ): First Half Of 2014: Broadened Clinical Portfolio And Strengthened Cash Position     9/17/2014
Synairgen plc Release: Notice Of Interim Results     9/17/2014
Neumedicines Inc. Names David L. Morash President And Chief Strategy Officer     9/17/2014
Alexion Pharmaceuticals Inc. (ALXN) Strengthens and Broadens Its Executive Leadership Team     9/17/2014
IXICO plc Release: Appointment Of Chief Financial Officer     9/17/2014
Nora Therapeutics Names Sandra Shpilberg Vice President, Strategic Marketing & Commercial Planning     9/17/2014
BASi (BASI) Names Connie Dougherty Vice President Business Development     9/17/2014
Christy Noland To Lead Urology Advocacy And Communications For Astellas Pharma Inc. (ALPMY)     9/17/2014
Axsome Therapeutics Announces Appointments To Its Board Of Directors     9/17/2014
Bristol-Myers Squibb Company (BMY) Announces Dividend     9/17/2014
Corium International, Inc. Announces Appointment Of Paul Goddard, Ph.D. To Board Of Directors     9/17/2014
Marina Biotech, Inc. (MRNA) Announces The Election Of Donald A. Williams To Its Board Of Directors     9/17/2014
OncoSec Medical Inc. Expands Legal Team, Appoints Sheela Mohan-Peterson As General Counsel And Corporate Secretary     9/17/2014
Retrophin, Inc. (RTRX) Announces Changes To Board Of Directors And Management Team     9/17/2014
Cancer Geneticist, Alberto Bardelli, Ph.D., Joins TrovaGene, Inc.'s Scientific Advisory Board     9/17/2014
American Academy of HIV Medicine Release: Olympian Greg Louganis Shares Personal Experience On Aging With HIV Exclusively On HIV-Age.Org     9/17/2014
Can-Fite BioPharma (CFBI)'s Drug CF101 Is Presented In Scientific Journal As One Of Four Small Molecule Drugs For The Treatment Of Psoriasis     9/17/2014
TransCelerate BioPharma Publishes Risk-Based Monitoring Recommendations For Central Monitoring And Technology Considerations     9/17/2014
The Edmond J. Safra National Parkinson's Wellness Initiative Launched By The National Parkinson Foundation, NYU Langone Medical Center, And The Jewish Community Center In Manhattan     9/17/2014
BIOCOM Recognizes National Health IT Week     9/17/2014
Biotechnology Industry Organization (BIO) Praises House Of Representatives For Passing The Promoting Job Creation And Reducing Small Business Burdens Act     9/17/2014
Cara Therapeutics, Inc. (CARA) To Sponsor Symposium At American Academy Of Pain Management 2014 Annual Clinical Meeting     9/17/2014
Orexigen Therapeutics, Inc. (OREX) To Present At The Bank of America (BAC) Merrill Lynch Global Healthcare Conference     9/17/2014
Neuraltus Pharmaceuticals, Inc.' ALS Treatment Candidate, NP001, Highlighted At ALS Research Group Summit     9/17/2014
Intarcia Therapeutics, Inc. Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies     9/17/2014
Exelixis, Inc. (EXEL) Announces Cobimetinib Phase 3 coBRIM Results To Be Presented At ESMO 2014 Congress     9/17/2014
American Academy of Ophthalmology's Annual Meeting To Showcase Latest in Eye Care Research, Technology, Clinical Education and Legislation     9/17/2014
BioClinica, Inc. To Present At 20th Annual SCDM Conference     9/17/2014
Bayer Corporation (BAY) To Present Data On Hemophilia Research At NHF In Washington, D.C.     9/17/2014
Catalent, Inc. To Present At The Deutsche Bank (DB) 2014 Leveraged Finance Conference     9/17/2014
KineMed, Inc. To Showcase Advances In Dynamic Proteomic Markers Of Neurodegenerative Disease At The 8th Annual Neurodegenerative Conditions Research & Development Conference     9/17/2014
IntelGenx Corp. To Present At Singular Research 9th Annual Best Of The Uncovereds Conference     9/17/2014
Roper Industries To Present At Citi's 2014 Industrials Conference     9/17/2014
Momenta Pharmaceuticals, Inc. (MNTA) To Webcast Presentation At Biocentury's Newsmakers In The Biotech Industry Conference     9/17/2014
OncoMed Pharmaceuticals, Inc. (OMED) To Present New And Emerging Data From Demcizumab (Anti-DLL4, OMP-21M18) And Tarextumab (Anti-Notch2/3, OMP-59R5) Clinical Studies At The European Society For Medical Oncology 2014 Congress     9/17/2014
Roche (RHHBY) To Present Latest Oncology Advances During ESMO 2014 Congress     9/17/2014
Oxford Gene Technology Ltd. Presents The Latest In Tumour Screening At BSGM     9/17/2014
Exco Intouch Presents At HealthXL Event In San Francisco To Drive Innovation In mHealth Solution 17-19 September 2014     9/17/2014
Ignyta (RXDX) To Participate In Precision Medicine Panel Discussions With Other Thought Leaders     9/17/2014
Clinical Data On AVEO Oncology (AVEO)’s Ficlatuzumab And Tivozanib To Be Presented At The ESMO 2014 Congress     9/17/2014
Arch Therapeutics Co-Founder Rutledge Ellis-Behnke To Speak At 12th Annual Current Issues In Medicine, Biotech And Pharma Conference On September 18     9/17/2014
Boston Therapeutics, Inc. To Present At National Investment Banking Conference On September 16, 2014     9/17/2014
Event Report: Cellectis (ALCLS) R&D/ Analyst Day     9/17/2014
Boston Therapeutics, Inc. To Present Findings Of BTI-320 As Therapy For Glycemic Control At 50th Annual Meeting Of European Association For The Study Of Diabetes     9/17/2014
ZS Pharma (ZSPH) To Present At The 21st Annual Biocentury Newsmakers Conference     9/17/2014

Career Tips
How Biotechs Are Focusing On Employee Retention     9/22/2014
Pfizer (PFE) And Merck & Co. (MRK) Execs Exclusive: Inside Tips For Getting Hired     9/16/2014
6 Job Interview Blunders To Avoid     9/11/2014
What You MUST Ask Before You Leave The Interview     9/11/2014
Repairing Your Cover Letter And Resume After Getting Fired     9/11/2014
10 Types Of Positive And Negative Networkers     9/11/2014
How To Craft An Attention-Getting Resume     9/11/2014
Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc. (ARNA)     8/26/2014
Best Biotech Employers In America     8/26/2014
4 Untrue Things Biotech Employers May Tell Candidates     8/21/2014
Top 31 Common Interview Questions And Answers     8/21/2014
6 Tips To Ace Your Next Phone Interview     8/21/2014
How NOT To Write Your Resume     8/21/2014
Cover Letters For The Overqualified: How To Get Your Foot In The Door     8/21/2014
7 Reasons Why Recruiters And Employers Dread Reading A Resume     8/21/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->